857
Views
7
CrossRef citations to date
0
Altmetric
Letter

Cytomegalovirus Retinitis in a Patient with Proliferative Diabetes Retinopathy

, , &
Pages 225-226 | Received 10 Nov 2012, Accepted 27 Dec 2012, Published online: 12 Mar 2013

Figures & data

Figure 1. Fundus of left eye during vitrectomy. During vitreous surgery, a yellowish white retinal exudative lesion involving the posterior pole and whitening inside vascular arcades are observed, both of which are atypical findings of PDR. Proliferative membrane was around the disc.

Figure 1. Fundus of left eye during vitrectomy. During vitreous surgery, a yellowish white retinal exudative lesion involving the posterior pole and whitening inside vascular arcades are observed, both of which are atypical findings of PDR. Proliferative membrane was around the disc.

Figure 2. Fundus of left eye after treatment. (A) Macular color photograph and (B) macular fluorescein angiography. Ganciclovir therapy (600 mg/day) for 3 weeks achieved successful remission of the retinal lesion, but visual acuity of the left eye did not improve since macular atrophy had already progressed.

Figure 2. Fundus of left eye after treatment. (A) Macular color photograph and (B) macular fluorescein angiography. Ganciclovir therapy (600 mg/day) for 3 weeks achieved successful remission of the retinal lesion, but visual acuity of the left eye did not improve since macular atrophy had already progressed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.